Kerman University of Medical Sciences International Journal of Health Policy and Management 2322-5939 6 12 2017 12 01 New Health Technologies: A UK Perspective; Comment on “Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies” 721 722 3358 10.15171/ijhpm.2017.59 EN Nassim Parvizi Oxford University Hospitals NHS Foundation Trust, Oxford, UK Sahar Parvizi Moorfields Eye Hospital NHS Foundation Trust, London, UK Journal Article 2017 02 27 New health technologies require development and evaluation ahead of being incorporated into the patient care pathway. In light of the recent publication by Lehoux et al who discuss the role of entrepreneurs, investors and regulators in providing value to new health technologies, we summarise the processes involved in making new health technologies available for use in the United Kingdom. Health Technology Health Technology Assessment (HTA) National Institute of Health Research (NIHR) National Institute for Health and Care Excellence (NICE) https://www.ijhpm.com/article_3358_eaa713a92c3148cf2ace72933620b97c.pdf